SILK Silk Road Medical, Inc.: Debt to Book Capitalization Ratio

Official company branding of Silk Road Medical, Inc (SILK)

High margins and patent protection create a stable cash flow, supporting the operational peak of Silk Road Medical, Inc (SILK). The debt-to-book capitalization trend on the GURU.Markets service demonstrates that the metric has reached the level of 0.59. Success is based on US-based production of TCAR systems and the absolute trust of surgeons in the safety of stroke prevention methods.

Silk Road Medical, Inc - SILK Debts to Book Capitalization (period 07/04/2022 - 09/28/2024)
Product sample of Silk Road Medical Inc

This ratio assesses the proportion of borrowed funds relative to equity, determining the company's financial autonomy. A decrease in this metric minimizes default risks, although a complete avoidance of loans limits growth rates. By analyzing the debt-to-equity coverage ratio, an investor can see the balance between stability and aggressive growth. For Silk Road Medical, Inc (SILK), this is critical when scaling the supply of minimally invasive surgery systems. An optimal debt level ensures the expansion of carotid artery treatment technologies without the threat of bankruptcy.

Competing companies

Debts to Book Capitalization DXCM (DexCom, Inc.)|penumbrainc.com (PEN) - Debts to Book Value|NOVT - Debt to Book Capitalization Ratio|Debt to Net Assets Ratio HAE (Haemonetics Corp)|INSP: Debts to Book Capitalization|Procept (PRCT) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation|pulsebiosciences.com - Debts to Book Capitalization Ratio|Debts to Book Capitalization INMD|PMI - Debts to Book Value|Surmodics Corp - Debt to Book Value|Debts to Book Capitalization Senseonics SENS|NPCE: Debt to Book Value|Tactile Systems Technology - Debt to Book Capital|SNWV: Debts to Book Capitalization|OM - Debts to Net Assets|ELMD (SmartVest) - Debts to Book Capitalization|Debt to Book Value LENSAR Inc (LNSR)|Debt to Book Value RCEL (AVITA Medical, Inc.)|PROF (profoundmedical.com) - Debt to Net Assets Ratio|Debt to Book Capitalization Ratio Baird Medical BDMD|EDAP - Debt to Book Value|Bovie Medical - Debts to Book Capitalization|Debts to Book Value IceCure Medical Ltd|LUNG: Debts to Book Capitalization|Debt to Book Value Ratio TELA|CTSO (CytoSorbents Corp) - Debts to Book Capitalization|Sensus Healthcare Inc (SRTS) - Debts to Net Assets|Debts to Book Capitalization ZYXI|Debt to Book Value electrocore.com ECOR|Debts to Book Capitalization RBOT (Vicarious Surgical)|Debts to Book Capitalization Inspira Technologies Oxy B.H.N. Ltd. IINN|ICU - Debt to Book Capitalization Ratio|IRIX: Debt to Book Capitalization Ratio|INBS (ibs.inc) - Debt to Book Value|Beyond Air - Debt to Net Assets Ratio|PFSA (Profusa Inc) - Debts to Book Capitalization|Debts to Book Value STRATA Skin SSKN|Debt to Book Capitalization Ratio GlucoTrack (GCTK)|NanoVibronix Inc. (NAOV) - Debt to Net Assets|Venus Concept Corp - Debt to Book Value|Debts to Book Capitalization Nuwellis Corp NUWE|Aethlon Medical - Debts to Book Capitalization|Debts to Net Assets Asensus Surgical, Inc. ASXC|Avinger (AVGR) - Debt to Book Capitalization Ratio|Debts to Book Capitalization Ratio BSGM (biosig.com)|Debt to Book Capitalization Ratio Cutera, Inc|Debt to Book Value Know Labs Corporation (KNW)|Debts to Book Capitalization NARI|NVRO - Debts to Book Value|Debt to Book Capitalization Ratio ReShape Lifesciences Inc. RSLS